Hepatitis B serological markers and plasma DNA concentrations.
Identifieur interne : 000D19 ( PubMed/Corpus ); précédent : 000D18; suivant : 000D20Hepatitis B serological markers and plasma DNA concentrations.
Auteurs : Huw Price ; David Dunn ; Tamale Zachary ; Tobias Vudriko ; Michael Chirara ; Cissy Kityo ; Paula Munderi ; Moira Spyer ; James Hakim ; Charles Gilks ; Pontiano Kaleebu ; Deenan Pillay ; Richard GilsonSource :
- AIDS (London, England) [ 1473-5571 ] ; 2017.
Abstract
To examine hepatitis B (HBV) serological markers and plasma DNA concentrations in a large group of untreated HBV/HIV-coinfected individuals in two sub-Saharan settings.
DOI: 10.1097/QAD.0000000000001454
PubMed: 28328795
Links to Exploration step
pubmed:28328795Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hepatitis B serological markers and plasma DNA concentrations.</title><author><name sortKey="Price, Huw" sort="Price, Huw" uniqKey="Price H" first="Huw" last="Price">Huw Price</name><affiliation><nlm:affiliation>Centre for Sexual Health and HIV Research, Mortimer Market Centre, University College London</nlm:affiliation></affiliation></author><author><name sortKey="Dunn, David" sort="Dunn, David" uniqKey="Dunn D" first="David" last="Dunn">David Dunn</name><affiliation><nlm:affiliation>MRC Clinical Trials Unit at University College London, London, UK</nlm:affiliation></affiliation></author><author><name sortKey="Zachary, Tamale" sort="Zachary, Tamale" uniqKey="Zachary T" first="Tamale" last="Zachary">Tamale Zachary</name><affiliation><nlm:affiliation>Joint Clinical Research Centre, Kampala</nlm:affiliation></affiliation></author><author><name sortKey="Vudriko, Tobias" sort="Vudriko, Tobias" uniqKey="Vudriko T" first="Tobias" last="Vudriko">Tobias Vudriko</name><affiliation><nlm:affiliation>MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda</nlm:affiliation></affiliation></author><author><name sortKey="Chirara, Michael" sort="Chirara, Michael" uniqKey="Chirara M" first="Michael" last="Chirara">Michael Chirara</name><affiliation><nlm:affiliation>University of Zimbabwe, Harare, Zimbabwe</nlm:affiliation></affiliation></author><author><name sortKey="Kityo, Cissy" sort="Kityo, Cissy" uniqKey="Kityo C" first="Cissy" last="Kityo">Cissy Kityo</name><affiliation><nlm:affiliation>Joint Clinical Research Centre, Kampala</nlm:affiliation></affiliation></author><author><name sortKey="Munderi, Paula" sort="Munderi, Paula" uniqKey="Munderi P" first="Paula" last="Munderi">Paula Munderi</name><affiliation><nlm:affiliation>MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda</nlm:affiliation></affiliation></author><author><name sortKey="Spyer, Moira" sort="Spyer, Moira" uniqKey="Spyer M" first="Moira" last="Spyer">Moira Spyer</name><affiliation><nlm:affiliation>MRC Clinical Trials Unit at University College London, London, UK</nlm:affiliation></affiliation></author><author><name sortKey="Hakim, James" sort="Hakim, James" uniqKey="Hakim J" first="James" last="Hakim">James Hakim</name><affiliation><nlm:affiliation>University of Zimbabwe, Harare, Zimbabwe</nlm:affiliation></affiliation></author><author><name sortKey="Gilks, Charles" sort="Gilks, Charles" uniqKey="Gilks C" first="Charles" last="Gilks">Charles Gilks</name><affiliation><nlm:affiliation>School of Population Health, University of Queensland, Brisbane, Australia</nlm:affiliation></affiliation></author><author><name sortKey="Kaleebu, Pontiano" sort="Kaleebu, Pontiano" uniqKey="Kaleebu P" first="Pontiano" last="Kaleebu">Pontiano Kaleebu</name><affiliation><nlm:affiliation>MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda</nlm:affiliation></affiliation></author><author><name sortKey="Pillay, Deenan" sort="Pillay, Deenan" uniqKey="Pillay D" first="Deenan" last="Pillay">Deenan Pillay</name><affiliation><nlm:affiliation>Africa Health Research Institute, Durban, South Africa</nlm:affiliation></affiliation></author><author><name sortKey="Gilson, Richard" sort="Gilson, Richard" uniqKey="Gilson R" first="Richard" last="Gilson">Richard Gilson</name><affiliation><nlm:affiliation>Centre for Sexual Health and HIV Research, Mortimer Market Centre, University College London</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28328795</idno><idno type="pmid">28328795</idno><idno type="doi">10.1097/QAD.0000000000001454</idno><idno type="wicri:Area/PubMed/Corpus">000D19</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D19</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Hepatitis B serological markers and plasma DNA concentrations.</title><author><name sortKey="Price, Huw" sort="Price, Huw" uniqKey="Price H" first="Huw" last="Price">Huw Price</name><affiliation><nlm:affiliation>Centre for Sexual Health and HIV Research, Mortimer Market Centre, University College London</nlm:affiliation></affiliation></author><author><name sortKey="Dunn, David" sort="Dunn, David" uniqKey="Dunn D" first="David" last="Dunn">David Dunn</name><affiliation><nlm:affiliation>MRC Clinical Trials Unit at University College London, London, UK</nlm:affiliation></affiliation></author><author><name sortKey="Zachary, Tamale" sort="Zachary, Tamale" uniqKey="Zachary T" first="Tamale" last="Zachary">Tamale Zachary</name><affiliation><nlm:affiliation>Joint Clinical Research Centre, Kampala</nlm:affiliation></affiliation></author><author><name sortKey="Vudriko, Tobias" sort="Vudriko, Tobias" uniqKey="Vudriko T" first="Tobias" last="Vudriko">Tobias Vudriko</name><affiliation><nlm:affiliation>MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda</nlm:affiliation></affiliation></author><author><name sortKey="Chirara, Michael" sort="Chirara, Michael" uniqKey="Chirara M" first="Michael" last="Chirara">Michael Chirara</name><affiliation><nlm:affiliation>University of Zimbabwe, Harare, Zimbabwe</nlm:affiliation></affiliation></author><author><name sortKey="Kityo, Cissy" sort="Kityo, Cissy" uniqKey="Kityo C" first="Cissy" last="Kityo">Cissy Kityo</name><affiliation><nlm:affiliation>Joint Clinical Research Centre, Kampala</nlm:affiliation></affiliation></author><author><name sortKey="Munderi, Paula" sort="Munderi, Paula" uniqKey="Munderi P" first="Paula" last="Munderi">Paula Munderi</name><affiliation><nlm:affiliation>MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda</nlm:affiliation></affiliation></author><author><name sortKey="Spyer, Moira" sort="Spyer, Moira" uniqKey="Spyer M" first="Moira" last="Spyer">Moira Spyer</name><affiliation><nlm:affiliation>MRC Clinical Trials Unit at University College London, London, UK</nlm:affiliation></affiliation></author><author><name sortKey="Hakim, James" sort="Hakim, James" uniqKey="Hakim J" first="James" last="Hakim">James Hakim</name><affiliation><nlm:affiliation>University of Zimbabwe, Harare, Zimbabwe</nlm:affiliation></affiliation></author><author><name sortKey="Gilks, Charles" sort="Gilks, Charles" uniqKey="Gilks C" first="Charles" last="Gilks">Charles Gilks</name><affiliation><nlm:affiliation>School of Population Health, University of Queensland, Brisbane, Australia</nlm:affiliation></affiliation></author><author><name sortKey="Kaleebu, Pontiano" sort="Kaleebu, Pontiano" uniqKey="Kaleebu P" first="Pontiano" last="Kaleebu">Pontiano Kaleebu</name><affiliation><nlm:affiliation>MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda</nlm:affiliation></affiliation></author><author><name sortKey="Pillay, Deenan" sort="Pillay, Deenan" uniqKey="Pillay D" first="Deenan" last="Pillay">Deenan Pillay</name><affiliation><nlm:affiliation>Africa Health Research Institute, Durban, South Africa</nlm:affiliation></affiliation></author><author><name sortKey="Gilson, Richard" sort="Gilson, Richard" uniqKey="Gilson R" first="Richard" last="Gilson">Richard Gilson</name><affiliation><nlm:affiliation>Centre for Sexual Health and HIV Research, Mortimer Market Centre, University College London</nlm:affiliation></affiliation></author></analytic><series><title level="j">AIDS (London, England)</title><idno type="eISSN">1473-5571</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To examine hepatitis B (HBV) serological markers and plasma DNA concentrations in a large group of untreated HBV/HIV-coinfected individuals in two sub-Saharan settings.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28328795</PMID><DateCreated><Year>2017</Year><Month>03</Month><Day>22</Day></DateCreated><DateRevised><Year>2017</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-5571</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Month>05</Month><Day>15</Day></PubDate></JournalIssue><Title>AIDS (London, England)</Title><ISOAbbreviation>AIDS</ISOAbbreviation></Journal><ArticleTitle>Hepatitis B serological markers and plasma DNA concentrations.</ArticleTitle><Pagination><MedlinePgn>1109-1117</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/QAD.0000000000001454</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To examine hepatitis B (HBV) serological markers and plasma DNA concentrations in a large group of untreated HBV/HIV-coinfected individuals in two sub-Saharan settings.</AbstractText><AbstractText Label="DESIGN">Baseline analysis of a randomized controlled trial.</AbstractText><AbstractText Label="METHODS">DART was a large trial of treatment monitoring practices in HIV-infected adults with advanced disease starting antiretroviral therapy at centres in Kampala or Entebbe, Uganda (n = 2317) and Harare, Zimbabwe (n = 999). HBV serological markers [antibody to HBV core antigen, HBV surface antigen (HBsAg), antibody to HBV surface antigen, HBV 'e' antigen (HBeAg), and antibody to hepatitis B 'e' antigen] and plasma HBV DNA viral load were measured retrospectively on stored baseline samples. Logistic regression was used to examine associations with baseline demographic and clinical factors.</AbstractText><AbstractText Label="RESULTS">The rate of HBsAg positivity was significantly higher in Zimbabwe than Uganda (12.2 vs. 7.7%, adjusted odds ratio = 1.54, P < 0.001) despite a similar prevalence of antibody to HBV core antigen (56.3 vs. 52.4%) in the two settings. Overall, HBsAg positivity was associated with male sex (adjusted odds ratio = 1.54, P < 0.001) but not with age, WHO disease stage, or CD4 cell count. HBeAg was detected among 37% of HBsAg-positive patients, with higher rates among those with advanced WHO stage (P = 0.02). Also in HBsAg-positive patients, HBV DNA was undetectable in 21%, detectable but below the level of quantification in 14%, and quantifiable in 65%. A total of 96% of HBeAg-positive and 70% of HBeAg-negative patients had detectable HBV DNA; 92 and 28% of patients, respectively, had HBV DNA viral load more than 2000 IU/ml.</AbstractText><AbstractText Label="CONCLUSION">High rates of HBV coinfection were observed, highlighting the importance of ensuring that coinfected patients receive an antiretroviral regimen, whether first-line or not, that is active against both viruses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Price</LastName><ForeName>Huw</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Sexual Health and HIV Research, Mortimer Market Centre, University College London</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunn</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>MRC Clinical Trials Unit at University College London, London, UK</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zachary</LastName><ForeName>Tamale</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Joint Clinical Research Centre, Kampala</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vudriko</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chirara</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Zimbabwe, Harare, Zimbabwe</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kityo</LastName><ForeName>Cissy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Joint Clinical Research Centre, Kampala</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munderi</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spyer</LastName><ForeName>Moira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MRC Clinical Trials Unit at University College London, London, UK</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hakim</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Zimbabwe, Harare, Zimbabwe</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilks</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Population Health, University of Queensland, Brisbane, Australia</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaleebu</LastName><ForeName>Pontiano</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillay</LastName><ForeName>Deenan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Africa Health Research Institute, Durban, South Africa</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilson</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Sexual Health and HIV Research, Mortimer Market Centre, University College London</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>DART Virology Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>AIDS</MedlineTA><NlmUniqueID>8710219</NlmUniqueID><ISSNLinking>0269-9370</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Antivir Ther. 2011;16(3):405-11</RefSource><PMID Version="1">21555823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J STD AIDS. 2010 Aug;21(8):553-7</RefSource><PMID Version="1">20975087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 Jan 9;375(9709):123-31</RefSource><PMID Version="1">20004464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 2010 Aug;82(8):1334-40</RefSource><PMID Version="1">20572076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Patient Care STDS. 2008 Oct;22(10 ):787-95</RefSource><PMID Version="1">18778241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2006 Aug 14-28;166(15):1632-41</RefSource><PMID Version="1">16908797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1977 Jun;74(6):2561-3</RefSource><PMID Version="1">267950</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J STD AIDS. 2012 Feb;23(2):149-50</RefSource><PMID Version="1">22422696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2016 Jul 17;30(11):1849-52</RefSource><PMID Version="1">27139315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Obstet Gynecol Reprod Biol. 2010 May;150(1):34-8</RefSource><PMID Version="1">20189288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Afr Health Sci. 2015 Jun;15(2):328-33</RefSource><PMID Version="1">26124776</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 1989 Jan;9(1):102-4</RefSource><PMID Version="1">2521178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2015 Jun 19;29(10):1173-82</RefSource><PMID Version="1">26035319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2016 Jan;63(1):261-83</RefSource><PMID Version="1">26566064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2006 Nov 17;24(47-48):6930-7</RefSource><PMID Version="1">17027122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 2006 Jun;44(6):2250-3</RefSource><PMID Version="1">16757632</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 2011 Jun;83(6):929-34</RefSource><PMID Version="1">21503902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 1987 May;22(1):1-5</RefSource><PMID Version="1">3585289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2009 Sep;50(3):661-2</RefSource><PMID Version="1">19714720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arthritis Rheum. 1979 Nov;22(11):1261-6</RefSource><PMID Version="1">508376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>S Afr Med J. 1996 Jan;86(1):72-5</RefSource><PMID Version="1">8685787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2009 Oct 15;49(8):1268-73</RefSource><PMID Version="1">19772386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2010 Jun 29;10:191</RefSource><PMID Version="1">20587047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antivir Ther. 2010;15(7):1029-34</RefSource><PMID Version="1">21041918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2002 Dec 14;360(9349):1921-6</RefSource><PMID Version="1">12493258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2005 Feb;34(1):121-30</RefSource><PMID Version="1">15561752</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 1999 May;28(5):1032-5</RefSource><PMID Version="1">10452630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Infect Dis. 2010 Dec;14(12):e1024-31</RefSource><PMID Version="1">20870439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 2007 Dec;79(12):1797-801</RefSource><PMID Version="1">17935164</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 1999 Nov;30(5):1302-6</RefSource><PMID Version="1">10534354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2012 Jul;57(1):167-85</RefSource><PMID Version="1">22436845</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 1991 Feb;33(2):95-9</RefSource><PMID Version="1">2051143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2010 May 15;50(10):1387-96</RefSource><PMID Version="1">20380565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 1990 Mar;8 Suppl:S15-7; discussion S21-3</RefSource><PMID Version="1">2327151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1984;78(4):514-8</RefSource><PMID Version="1">6091302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>East Afr Med J. 2002 Feb;79(2):68-72</RefSource><PMID Version="1">12380879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>HIV Med. 2012 Jan;13(1):1-44</RefSource><PMID Version="1">22171742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2008 Oct;49(4):652-7</RefSource><PMID Version="1">18715666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2015 Nov;109(11):723-9</RefSource><PMID Version="1">26386408</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28328795</ArticleId><ArticleId IdType="doi">10.1097/QAD.0000000000001454</ArticleId><ArticleId IdType="pmc">PMC5414544</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D19 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000D19 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28328795
|texte= Hepatitis B serological markers and plasma DNA concentrations.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28328795" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |